Syntax Bio's discovery platform overcomes the longstanding challenges in stem cell-derived therapies by directly controlling and accelerating cell differentiation. A shorter and more reliable cell differentiation process improves patient access by making discovery faster, less costly and scalable. Synatx’s proprietary Cellgorithm technology mimics human development using a sequential CRISPR-based system to generate a wide diversity of functional cell types to enable new product opportunities.

Biotechnology

Life Sciences

Therapeutics

Syntax Bio

The Chicago office focuses on scientific research and technological innovation to drive advancements in the biotech sector.

People (5)

Jobs (0)

Other offices